SERUM DOPAMINE BETA-HYDROXYLASE ACTIVITY AND TARDIVE-DYSKINESIA

被引：6

作者：

GLAZER, WM

MORGENSTERN, H

JESTE, DV

ZAHNER, G

HAFEZ, HM

BENARROCHE, CL

机构：

[1] YALE UNIV,SCH MED,DEPT PSYCHIAT,NEW HAVEN,CT 06510

[2] UNIV CALIF LOS ANGELES,SCH PUBL HLTH,DIV EPIDEMIOL,LOS ANGELES,CA 90024

[3] NIMH,INTRAMURAL RES PROGRAM,NEUROPSYCHIAT BRANCH,WASHINGTON,DC 20032

[4] YALE UNIV,SCH MED,CTR CHILD STUDY,NEW HAVEN,CT 06510

来源：

PSYCHONEUROENDOCRINOLOGY | 1987年 / 12卷 / 04期

关键词：

D O I：

10.1016/0306-4530(87)90053-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：289 / 294

页数：6

共 28 条

[1]

ARATO M, 1980, NEUROENDOCRINOL LETT, V6, P315

[2]

BACHER NM, 1980, AM J PSYCHIAT, V137, P495

[3]

BRIDGE TP, 1985, AGE ALCOHOL CATECHOL

[4]

BROWNE J, 1986, J CLIN PSYCHOPHARM, V6, P88

[5]

DELISI LE, 1981, BIOL PSYCHIAT, V16, P873

[6] CLONIDINE TREATMENT OF SCHIZOPHRENIA - DOUBLE-BLIND COMPARISON TO PLACEBO AND NEUROLEPTIC DRUGS [J].

FREEDMAN, R ;

KIRCH, D ;

BELL, J ;

ADLER, LE ;

PECEVICH, M ;

PACHTMAN, E ;

DENVER, P .

ACTA PSYCHIATRICA SCANDINAVICA, 1982, 65 (01) :35-45

[7]

GLAZER W, 1981, HOSP COMMUNITY PSYCH, V32, P572

[8]

Hollister LE, 1973, CLIN USE PSYCHOTHERA

[9]

JESTE DV, 1979, LANCET, V2, P850

[10]

JESTE DV, 1982, BIOL PSYCHIAT, V17, P199

← 1 2 3 →